Clinical Trial Update: Phase 2 Efficacy Study of Primaquine and Methylene Blue [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial evaluating the combination of primaquine and methylene blue for malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)
• Primaquine (primaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 2 | Status: COMPLETED